Related Experiment Video
Updated: Jul 5, 2026
06:20
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Uncertainties in internal dose calculations for radiopharmaceuticals
1Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, Tennessee 37232-2675, USA. michael.g.stabin@vanderbilt.edu
Summary
Internal dose calculations for radiopharmaceuticals have inherent uncertainties, often exceeding a factor of two. Patient-specific data can significantly reduce this uncertainty for therapeutic applications.
Area of Science:
- Nuclear Medicine
- Medical Physics
- Radiopharmaceutical Dosimetry
Background:
- Accurate internal dose calculation is crucial for radiopharmaceutical therapy and diagnostics.
- Inherent uncertainties in dose estimation can impact treatment efficacy and patient safety.
- Current methods for dose calculation require rigorous analysis of contributing factors.
Purpose of the Study:
- To systematically analyze the uncertainty in internal dose calculations for radiopharmaceuticals.
- To present a generic equation for internal dose and evaluate the uncertainty of its components.
- To explore methods for reducing uncertainty in patient-specific dose estimates.
Main Methods:
- A generic equation for internal dose calculation was developed.
- Uncertainty analysis was performed on each term of the equation.
- Relative uncertainties of all terms were compared.
- Methods for reducing uncertainty in patient-individualized absorbed dose calculations were investigated.
Main Results:
- Combined uncertainties in most radiopharmaceutical dose estimates are typically at least a factor of 2, and can be greater.
- Patient-individualized absorbed dose calculations, with accurate data and organ volume measurements, can reduce total uncertainty to +/-10%-20%.
- Small differences in dose estimates between diagnostic radiopharmaceuticals are less critical than other clinical factors.
Conclusions:
- Significant uncertainties exist in standard radiopharmaceutical internal dose calculations.
- Personalized dosimetry offers a substantial reduction in uncertainty for therapeutic applications.
- When selecting diagnostic radiopharmaceuticals, factors beyond minor dose differences, such as diagnostic accuracy and patient comfort, should be prioritized.
More Related Videos
Related Concept Videos
02:59Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:10Propagation of Uncertainty from Systematic Error
The atomic mass of an element varies due to the relative ratio of its isotopes. A sample's relative proportion of oxygen isotopes influences its average atomic mass. For instance, if we were to measure the atomic mass of oxygen from a sample, the mass would be a weighted average of the isotopic masses of oxygen in that sample. Since a single sample is not likely to perfectly reflect the true atomic mass of oxygen for all the molecules of oxygen on Earth, the mass we obtain from this particular...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:21Dose Size and Dosing Frequency: Determination Methods
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...